Advertisement

Chronic Cutaneous Lupus Erythematosus

  • Pooya Khan Mohammad Beigi
Chapter

Abstract

Cutaneous lupus can be classified into three main different forms based on its clinical presentation [1]:
  1. 1.

    Acute cutaneous LE (ACLE)

     
  2. 2.

    Subacute cutaneous LE (SCLE)

     
  3. 3.

    Chronic cutaneous LE (CCLE)

     

Keywords

Acute cutaneous LE (ACLE) Subacute cutaneous LE (SCLE) Chronic cutaneous LE (CCLE) Hyperkeratotic LE Lupus tumidus Lupus profundus ,Chilblain lupus Peripheral scaling Hyperpigmentation Trauma UV exposure Cold temperatures Infection Dermatitis Burns Keratoacanthoma Hypertrophic lichen Dermal elastin fibers Lupus tumidus Lupus profundus Chilblain lupus Biopsy Basement membrane Follicular plugging Mucin Perivascular lymphocytic Inflammation Adnexal involvement Photoprotection Corticosteroids Topical calcineurin inhibitors Systemic antimalarial therapy UVA UVB Smoking cessation Corticosteroids Fluocinonide Hydrocortisone Topical calcineurin inhibitors Intralesional Antimalarials Hydroxychloroquine (HCQ) Chloroquine Quinacrine 

References

  1. 1.
    Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol. 2009;10(6):365–81.  https://doi.org/10.2165/11310780-000000000-00000.CrossRefPubMedGoogle Scholar
  2. 2.
    Rothfield N, Sontheimer RD, Bernstein M. Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol. 2006;24(5):348–62.CrossRefPubMedGoogle Scholar
  3. 3.
    Ueki H. Koebner phenomenon in lupus erythematosus with special consideration of clinical findings. Autoimmun Rev. 2005;4(4):219–23.CrossRefPubMedGoogle Scholar
  4. 4.
    Tebbe B, Mansmann U, Wollina U, et al. Markers in cutaneous lupus erythematosus indicating systemic involvement: a multicenter study on 96 patients. Acta Derm Venereol. 1997;77(4):305–8.PubMedGoogle Scholar
  5. 5.
    Daldon PE, Macedo de Souza E, Cintra ML. Hypertrophic lupus erythematosus: a clinicopathological study of 14 cases. J Cutan Pathol. 2003;30(7):443–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Ruiz H, Sánchez JL. Tumid lupus erythematosus. Am J Dermatopathol. 1999;21(4):356–60.  https://doi.org/10.1097/00000372-199908000-00008.CrossRefPubMedGoogle Scholar
  7. 7.
    Rao TN, Ahmed K, Venkatachalam K. Lupus erythematosus profundus. Indian J Dermatol Venereol Leprol. 2010;76(4):448.  https://doi.org/10.4103/0378-6323.66612.CrossRefPubMedGoogle Scholar
  8. 8.
    Garza-Mayers AC, McClurkin M, Smith GP. Review of treatment for discoid lupus erythematosus. Dermatol Ther. 2016;29(4):274–83.  https://doi.org/10.1111/dth.12358.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Pooya Khan Mohammad Beigi
    • 1
    • 2
    • 3
  1. 1.Department of Health ManagementNew York Medical CollegeValhallaUSA
  2. 2.University of British ColumbiaVancouverCanada
  3. 3.Misdiagnosis AssociationSeattleUSA

Personalised recommendations